The world of innate immune cells has greatly expanded in recent years. Broadly it includes innate lymphoid cells (ILCs) together with an array of unconventional lymphocytes such as γδ T cells, CD1-restricted NKT cells, and mucosal-associated invariant T (MAIT) cells. ILCs are distinct from other newly described innate cells as they lack recombined antigen-specific receptors characteristic of B and T lymphocytes and many of the phenotypic lineage markers that define other immune cell subsets. Indeed, ILCs are enriched when the two genes Rag1 and Rag2 that regulate recombination machinery, selection, and diversity in other lymphocytes, are deleted. 
| INTRODUC TI ON
The world of innate immune cells has greatly expanded in recent years. Broadly it includes innate lymphoid cells (ILCs) together with an array of unconventional lymphocytes such as γδ T cells, CD1-restricted NKT cells, and mucosal-associated invariant T (MAIT) cells. ILCs are distinct from other newly described innate cells as they lack recombined antigen-specific receptors characteristic of B and T lymphocytes and many of the phenotypic lineage markers that define other immune cell subsets. Indeed, ILCs are enriched when the two genes Rag1 and Rag2 that regulate recombination machinery, selection, and diversity in other lymphocytes, are deleted. 1 Nevertheless, ILCs exhibit a number of features that are reminiscent of T cells implying that they may be the innate counterparts of adaptive lineages. 2 ILCs have generally been regarded to be an almost exclusively tissue-resident population found at the barrier surfaces such as the skin, lungs, and intestinal tract. 3 New evidence now suggests that colonization of tissues, replenishment, and rapid dissemination of ILCs depends at least partly on the capacity of these cells to move around the body in response to pro-inflammatory signals allowing them to fight infection and maintain immune homeostasis. Here, we discuss the specific transcriptional pathways that are essential to regulate the generation and maintenance of ILCs. We focus on how recent findings are reshaping our understanding of the complexity of homeostatic regulation at barrier surfaces forcing us to rebuild the rules by which we understand how the immune system operates.
| INNATE LYMPHOID CELL SUBS E TS
Innate lymphoid cells are a heterogeneous family of immune cells that have shed new light on the architecture of the immune response and our understanding of how immune protection is orchestrated. ILCs express germline-encoded receptors that enables them to respond rapidly to stimuli. In many cases, precisely how these receptors work has been unclear as little is known about the ligands activating the receptors. Recent evidence, however, suggests that NKp46 can recognize the cognate ligand complement factor P, 4 and NKp44 can recognize platelet-derived growth factor (PDGF)-DD produced by tumors, 5 highlighting additional crucial roles in recognizing soluble tissue components, in addition to recognition of pathogen-derived ligands [6] [7] [8] [9] to protect against infections and to mediate tissue repair.
This feature allows them to deliver front line defense against the continual assault on the body from both foreign and commensal organisms as well as antigens derived from food and environmental sources.
Although we have only recently been readily able to dissect the diversity of ILC populations due to their rarity, NK cells, and lymphoid tissue-inducer (LTi) cells were discovered more than 30 years ago. This established their prototypical roles in tumor immunosurveillance (NK cells) 5, 10 and in the formation of secondary lymphoid tissues (LTi cells) 11, 12 during embryogenesis, respectively. Our understanding of this family has now greatly expanded with the discovery of new previously unrecognized members that have been classified into three main subsets: ILC1, ILC2, and ILC3s. 13 These groupings are largely aligned with effector T cells and are based on their expression of transcription factors and cytokine profiles.
ILC1s predominantly produce IFN-γ following stimulation. They are defined by the surface receptors NK1.1 and NKp46 (CD335)
together with their lack of lineage specific markers (including CD3, CD4, CD8, CD19, CD11c, and transcription factor RORγt).
This reveals a heterogeneous population that can be further separated into NK cells (which express CD49b, also known as DX5) and non-NK ILC1s (which express CD49a or VLA-1α). Both NK cells and ILC1 express the transcription factor T-BET (encoded by
Tbx21), but generally only NK cells express EOMES (encoded by
Eomesodermin, also referred as T-box brain protein 2). These factors are associated with IFN-γ production and anti-tumoral activities.
NK cells and ILC1 also differ in their lifecycle as NK cells seem to continuously recirculate around the body while non-NK ILC1s appear to reside mostly in tissues such as the liver. In addition, it is likely that the specific tissues inhabited by ILC1 significantly influence their phenotype and function. For example, it has been shown that salivary gland ILC1 are phenotypically distinct from liver ILC1
or from intraepithelial ILC1. RORα (RAR-related orphan receptor α). 15 Some variability in the expression of ST2, KLRG1, and CD25 has been observed depending on the tissue location and stimulus, 16 while in most tissues, ICOS is reliably expressed and indeed required for their survival and cytokine production. ILC2 are mainly involved in responses to allergic stimuli and parasites and are thus found at several sites throughout the body including the lungs, spleen, gut, liver, and skin. 
| Development of early innate lymphoid progenitors in bone marrow
ILCs are thought to arise from all-lymphoid progenitors (ALPs) which contains the common lymphoid progenitor (CLP) and the IL-7Rα + multipotent ILC progenitors. 18, [22] [23] [24] [25] The major progenitor potential lies within the α 4 β 7 fraction of the CLP. 26 Although all ILCs derive from an IL-7Rα + progenitor, an additional stage, termed the early innate lymphoid progenitor (EILP) has recently been defined and notably is marked by the expression of the transcription factor T cell factor-1 (TCF-1, encoded by the gene Tcf7). 27 Tcf7 + progenitors expressed only low levels of IL-7Rα, Zbtb16 (also known as Plzf), and Id2 (Inhibitor of DNA binding 2). 27 What was distinct about this cell type was that it did not fit with the known linear progression of ILC differentiation that had been previously described.
Distinct from other members of the progenitor network, the EILP did not express IL-7Rα. This was perplexing but such a step in ILC differentiation could occur if EILPs did not arise from the ALP; or alternately, ILC progenitors could transition through a stage that depended on the downregulation and subsequent re-expression of IL-7Rα as normally occurs in developing thymocytes ( Figure 1 ). shown to be the dominant ILC population within the thymus after birth. 47 The accumulation of ILC2 in the thymus over time raises the possibility that type 2 cytokines produced by these cells play a role in supporting normal thymic function. However, the exact origin of both of these subsets is yet to be explored. 48, 49 Collectively, these findings challenge the notion that the bone marrow is the only source of ILCs in the adult and instead raises the idea that an evolutionary mechanism has arisen providing multiple pathways to generate ILCs to protect the body against insults. NK cell progenitor that shows a highly enriched capacity to generate NK cells. 55 These cells express the IL-2Rβ chain (CD122), Sca-1, IL-7Rα, and ID2 but lacked markers typically expressed on fully differentiated mature NK cells such as NK1.1, NKp46, and CD49b. 55 In the bone marrow, this progenitor further committed into NK progenitor (NKP) 55, 56 and subsequently into immature and mature NK cells under the influence of a core transcription program including but not restricted to Id2, 55 Gata3, 57 Nfil3, 58 Klf2, 59 Eomes, 60 Tbx21, 61 Tcf7, 27 Tox, 62 and Ets-1 ( Figure 2 
| The thymic pathway

| Key drivers of ILC subset differentiation
| ILC2
The development of ILC2 is guided by the core transcriptional 
| ILC3
RORγt is the cornerstone transcription factor identified as essential for the development of ILC3 98 and opened the door to the identification of the three major different subsets of ILC3 ( Figure 2 However, the resistance to MCMV infection identified in this study was a surprise and was correlated with enhanced IFN-γ expression. 82 Increased IFN-γ production was attributed to the reduction in expression of the gene Dok1 which has previously been proposed to augment IFN-γ. 116 However, enhanced IFN-γ expression was not observed in all studies of mice carrying the C14R mutation. 81 Using exome sequencing, more than 300 genes were found to differ be- 
| ILC plasticity and the common default pathway
The broad subsets of ILCs have, through the development of elegant and novel tools and vigorous investigation, been relatively wellelucidated. However, many questions remain around the programs that define each subpopulation, as well as the cellular and molecular triggers that allow so called "plasticity," or the capacity to adopt a 
| IMMUNE HOMEOS TA S IS AT MUCOSAL SURFACE S: ILC NE T WORK S IN THE G UT
The mucosa is colonized by the bulk of immune cells found in the body. These cells sense information from intestinal contents such as the trillions of microbes that inhabit the gut and food components.
This landscape poses considerable challenges to maintain health. To that end, the immune system is charged with the task of balancing responses to maintain mucosal homeostasis. Fending off invading pathogens is clearly important, but maintaining immune homeostasis at these highly vulnerable surfaces is perhaps the single most important function that prevents succumbing to disease. In both the gut and the lung, the epithelium physically separates microbes from the immune cells but a constant dialogue between these compartments drives the integration of signals that guides homeostasis.
For example, in addition to physical interactions between microbes and immune cells, it has been uncovered that metabolites generated by microbes provide essential signals to immune cells in the hostmicrobiota homeostatic network. 
| Maintaining ILC at mucosal surfaces
132-134
Establishing this exclusivity was facilitated by generation of an IL-25
reporter mouse line. This mouse also revealed that Tuft cells were not the source of other important epithelial cytokines such as IL-33 and thymic stromal lymphopoietin (TSLP) that can also activate ILC2. 35 Elucidation of this pathway is exciting and prompts us to ask whether other novel cell types found in the intestine, which as yet relatively poorly characterized, might also contribute to maintaining the ILC network and the elegant cooperation between epithelial and immune cells that drives homeostatic balance between ILC2 and ILC3.
| Tissue residency and circulation
Except for NK cells which are mostly circulating, 135, 136 ILCs have generally been thought to be largely restricted to the tissues in which they are found, having established their niche early in ontogeny. 137, 138 This view of ILCs is predicated on several pieces of evidence including (a) ILCs are poorly replaced following transplantation, 137, 139 (b) mature ILCs do not appear to exchange between mice in which the circulatory system is conjoined in models of parabiosis, 137 and (c) few ILC that express a mature phenotype are found in the bone marrow. 18, 71 In mice ILC replacement is extremely poor following exposure to lethal doses of γ-irradiation, 137 and in patients who display mutations in the common γ chain cytokine receptor subunit IL-2Rγ, or the tyrosine kinase JAK3, tissue ILCs fail to be effectively reconstituted. 139 In part, this has been attributed to the extremely slow turnover of ILCs. 140 is necessary for the accumulation of NK cells in the liver. 155 Thus, multiple organs harbor a significant reservoir of NK cells separate from those found in the blood and under certain physiological conditions such as pregnancy, 156 or atopic or contact dermatitis, 157, 158 these are massively expanded.
From an evolutionary perspective, the notion that ILCs might only be replenished from local sources would leave the body extremely vulnerable-ILCs would be exposed to depletion by a severe highly acute infection, or more damaging long-term by a chronic infection without a mechanism to quickly deploy progenitors, or differentiated cells, to replace these cells. Local proliferation could provide some protection, but this is likely to be limited and an infection rapidly outstrip the capacity to generate new cells. Thus, the immune system would be quickly disabled, compromising the mucosal barrier in a life-threatening manner, and negating the principal role of ILC in maintaining these barriers.
The mechanisms that supports the expansion and contraction of 
| ILC3 are essential to maintain immune homeostasis
ILC3 are highly enriched in the gut mucosal tissues and rapidly respond to the cytokine milieu elicited by the colonization of microbes.
Often, we view the role of these cells through the lens of driving immune protection. It is, however, the ability to maintain immune homeostasis that is one of the most fundamental aspects that ensures our health. This requires the capacity of the barrier tissues to con- 
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